Article info

other Versions

PDF

Extended report
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years
  1. Correspondence toJosef S Smolen, Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna and The Center for Rheumatic Diseases, Hietzing Hospital, Vienna A-1090, Austria; josef.smolen{at}wienkav.at
View Full Text

Citation

Rahman MU, Buchanan J, Doyle MK, et al
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years

Publication history

  • Accepted 1 May 2011
  • Published in print 1 June 2011.
  • Published online 27 June 2011.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.